Esophageal cancer, esophagogastric junction cancer Esophageal cancer, esophagogastric junction cancer
Conditions
Interventions
Performing the abdominal part of mediastinoscopic esophagectomy robotically, up to transhiatal middle mediastinal dissection
D065287, D008481
Robotic-assisted, mediastinoscopic esophagectomy
Sponsors
Ogawa Koichi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Cases of thoracic esophageal cancer and esophagogastric junction cancer of cStage I-III (12th edition of the Japanese Code of Cancer of the Esophagus) 2) Any histological type 3) Age between 20 and 84 years at the time of consent 4) Any gender and BMI 5) Cervical esophagogastric tube reconstruction is possible (stomach can be used as a reconstructive organ) 6) Patients with preserved function of major organs (spinal cord, heart, lungs, liver, etc.) who are deemed eligible for general anesthesia and surgery. 7) Patients who have been properly informed about the participation in this study, and who have given their free and voluntary written consent based on full understanding of the study.
Exclusion criteria
Exclusion criteria: 1) Cervical esophageal cancer cases 2) Cases in which robotic/laparoscopic surgery is not possible (e.g., severe intra-abdominal adhesions) 3) ECOG-PS2 or higher 4) Patients with poorly controlled diabetes mellitus 5) Severely impaired cardiac function (EF < 30%)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of postoperative recurrent laryngeal nerve palsy | — |
Secondary
| Measure | Time frame |
|---|---|
| Perioperative complications other than recurrent nerve palsy (bleeding (intraoperative and postoperative), infection (intra-abdominal abscess, wound infection), suture failure, anastomotic stricture, pancreatic leakage and pancreatitis, delayed excretion of gastric contents, mastoidectomy, mastoabdomen, pneumothorax, hemothorax, pyothorax, tracheal necrosis, tracheal perforation, reconstructed organ necrosis, pulmonary embolism, other organ injury, cardiovascular, pulmonary and cerebral vascular infarction (e.g., pneumoperitoneum, intestinal obstruction, pneumonia, heart failure, liver failure, renal failure, abdominal wall scar hernia), open chest/open abdomen conversion rate, presence of blood transfusion, rate of surgery-related death, operation time, blood loss, number of lymph nodes dissected, postoperative hospital stay, rate of R0 resection | — |
Contacts
Public ContactKoichi Ogawa
University of Tsukuba
Outcome results
None listed